Taken together, erastin could suppress tumor growth of ovarian cancer, which was partly diminished by SNAI2 overexpression, suggesting that SNAI2 might exert tumor-promoting activity by regulating ferroptosis. The gene discussed is SNAI2; the disease is ovarian carcinoma.